GET /api/v0.1/hansard/entries/829133/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 829133,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/829133/?format=api",
    "text_counter": 202,
    "type": "speech",
    "speaker_name": "Murang’a CWR, JP",
    "speaker_title": "Hon. (Ms.) Sabina Chege",
    "speaker": {
        "id": 884,
        "legal_name": "Sabina Wanjiru Chege",
        "slug": "sabina-wanjiru-chege"
    },
    "content": "The Committee has proposed to provide additional terms that are used in the Act but have previously not been included in the interpretation section such as “good manufacturing practice”, “pharmaceutical device” and “pharmaceutical technologist”. The proposed amendment further seeks to introduce interpretation of various technical terms, as used in the Act such as “clinical trials”, “health products”, “health technology”, “medicinal substances” and “medical device”. The Committee looked at the terms as per the World Health Organisation’s definitions. I therefore move the amendment."
}